Drug makers have long flocked to sleep, trying to develop treatments to help people snooze longer and more soundly. But they’ve barely scratched the surface in exploiting the emerging connection between poor sleep and the inflammation that plays a key role in conditions like rheumatoid arthritis, lupus, and HIV/AIDS.
That overlooked connection has big potential, several top academic sleep researchers say.
About the Author Reprints
